VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW O SCHUMAKER | — |
| SAMANTHA VENTIMIGLIA | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate and international tax policy and research and development tax credits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW O SCHUMAKER | — |
| SAMANTHA VENTIMIGLIA | — |
Budget/Appropriations BUD
Issues related to funding for the Food and Drug Administration - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act; General education about policies to improve outcomes for patients with APOL-1 kidney disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW O SCHUMAKER | — |
| SAMANTHA VENTIMIGLIA | — |
Medicare/Medicaid MMM
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW O SCHUMAKER | — |
| SAMANTHA VENTIMIGLIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.